Loading clinical trials...

COVID-19 Antibody Levels After Vaccines | Clinical Trials | Clareo Health

COMPLETEDNCT04944134

COVID-19 Antibody Levels After Vaccines

This study will measure the levels of nasal mucosal Immunoglobulin A (IgA) and blood serum IgA up to one year after COVID vaccination, as well as examining what factors might affect antibody levels in...

Lead sponsor: University of North Carolina, Chapel Hill•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETEDPhase 3

Using BCG to Protect Senior Citizens During the COVID-19 Pandemic

NCT04542330 · Covid19, Non-specific Effects of Vaccines, and more

UNKNOWNPhase 4

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province

NCT04817917 · Japanese Encephalitis, Vaccine Preventable Disease, and more

UNKNOWNPhase 2/3

Study of Gam-COVID-Vac in Adolescents

NCT04954092 · Covid19, Vaccine Preventable Disease

WITHDRAWNPhase 4

COVID-19 Vaccine For Indirect Protection

NCT04818736 · Vaccine Preventable Disease

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 1, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment71

Start dateJun 2021

Last updatedAug 1, 2022

Condition

Vaccine Preventable Disease

Locations shown

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 1, 2022Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions